Holen Sie sich die Stockscreener-App
0.4999
15.13%
0.0657
Handel nachbörslich:
.48
-0.0199
-3.98%
Finanzdaten der Actuate Therapeutics Inc-Aktie (ACTU)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
14.01%
4.9066
|
5.706 | 4.6885 | 5.4724 | 5.9689 |
| Operating Income/Loss |
14.01%
-4.9066
|
-5.706 | -4.6885 | -5.4724 | -5.9689 |
| Nonoperating Income/Loss |
50.19%
0.04
|
0.0802 | 0.1345 | 0.0649 | 0.0195 |
| Net Income/Loss |
13.49%
-4.8666
|
-5.6257 | -4.554 | -5.4075 | -5.9494 |
| Basic Average Shares |
1.42%
23.87
|
23.54 | - | 21.39 | 19.65 |
| Diluted Average Shares |
1.42%
23.87
|
23.54 | - | 21.39 | 19.65 |
| Basic Earnings Per Share |
16.67%
-0.20
|
-0.24 | - | -0.25 | -0.30 |
| Diluted Earnings Per Share |
16.67%
-0.20
|
-0.24 | - | -0.25 | -0.30 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):